Literature DB >> 713437

[Calcium and phosphate metabolism in hemofiltration (author's transl)].

C Fuchs, D Dorn, H V Henning, D Matthaei, C McIntosh, P Kramer, D Ritter, B Schünemann, F Scheler.   

Abstract

In 10 patients undergoing hemofiltration treatment acute changes of parameters in the calcium-phosphate metaboism were investigated. Balance studies were also performed in all patients. Control studies were conducted after a 3-month interval in 7 patients. Whereas ionized calcium and 25-HCC remained constant, there was a significant decrease in phosphate, magnesium, fluoride and parathyroid hormone. Corresponding to these results, negative balances could be seen during the course of a hemofiltration treatment: for phosphate a mean value of -593 mg, for magnesium -8.4 mEq and for fluoride -458 microgram. When a calcium content of 3.75 mEq/l was used in the substitution solution, an only slightly positive calcium balance of +1.51 mEq/l (mean value) was found. A significant correlation between calcium and fluid balance was demonstrated by means of 197 filtration treatments of one patient: the calcium balance became negative whenever the fluid loss was greater than 3.86 liters. After a 3-month period no significant changes in the above parameters were found, which indicates, that disturbances in the calcium-phosphate-parathyroid hormone metabolism do not only lie in a reduced renal elimination. Even though our results do not indicate that hemofiltration treatment induces or increases the chances of renal osteodystrophy, the calcium concentration of the substitution solution should be increased to 4.0 mEq/l, in order to guarentee a positive calcium balance even by forced filtration.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 713437     DOI: 10.1007/bf01476860

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  17 in total

1.  [Radiological, biochemical and clinical aspects of uremic osteopathy in patients with long term dialysis].

Authors:  F J Frey; A J Jonutis; Z Bergstein; J Hodler; W Flury
Journal:  Schweiz Med Wochenschr       Date:  1976-10-16

2.  Comparative calcium ion determinations in plasma and whole blood with a new calcium ion analyzer.

Authors:  C Fuchs; D Dorn; C McIntosh; F Scheler; B Kraft
Journal:  Clin Chim Acta       Date:  1976-02-16       Impact factor: 3.786

3.  Dailysate calcium and plasma calcium fractions during and after haemodialysis.

Authors:  C Fuchs; M Brasche; U Donath-Wolfram; J Kubosch; E Quellhorst; F Scheler
Journal:  Klin Wochenschr       Date:  1975-01

4.  Metabolism of human PTH by the kidney and the liver.

Authors:  J Corvilain; T Manderlier; J Struyven; M Fuss; A Bergans; N Nijs; H Brauman
Journal:  Horm Metab Res       Date:  1977-05       Impact factor: 2.936

5.  A rapid assay for 25-OH-vitamin D3 without preparative chromatography.

Authors:  R E Belsey; H F DeLuca; J T Potts
Journal:  J Clin Endocrinol Metab       Date:  1974-06       Impact factor: 5.958

6.  Net intestinal absorption of calcium in patients with chronic renal failure.

Authors:  E M Clarkson; J B Eastwood; K G Koutsaimanis; H E de Wardener
Journal:  Kidney Int       Date:  1973-04       Impact factor: 10.612

7.  [Determination of ionized calcium in serum with an ion-selective flow-thru-electrode. Method and normal values].

Authors:  C Fuchs; K Paschen; P G Spieckermann; C von Westberg
Journal:  Klin Wochenschr       Date:  1972-09-01

8.  Hemofiltration: treatment of renal failure by ultrafiltration and substitution.

Authors:  E Quellhorst; B Doht; B Schuenemann
Journal:  J Dial       Date:  1977

9.  Activation of renal cortical adenylate cyclase by circulating immunoreactive parathyroid hormone fragments.

Authors:  J M Canterbury; G S Levey; E Reiss
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

10.  Radioimmunoassay of human parathyroid hormone in serum.

Authors:  C D Arnaud; H S Tsao; T Littledike
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.